Cytonet's Acquisition

Cytonet was acquired by Promethera Biosciences on April 18, 2016.

Cytonet develops and manufactures liver cell therapy products which, using specially prepared human cells, can stabilize patients with certain diseases until they receive a liver transplant.…

Articles about Cytonet's Acquisition: